A bill to prioritize funding for an expanded and sustained national investment in biomedical research.
The bill’s titles are written by its sponsor.
Jan 28, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on January 28, 2015, in a previous session of Congress, but was not enacted.
Senior Senator from Illinois
Read Text »
Last Updated: Jan 28, 2015
Length: 11 pages
Mar 12, 2014
Earlier Version — Introduced
This activity took place on a related bill, S. 2115 (113th).
Jan 28, 2015
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Mar 15, 2017
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 640.
S. 289 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). S. 289 — 114th Congress: American Cures Act. Retrieved from https://www.govtrack.us/congress/bills/114/s289
“S. 289 — 114th Congress: American Cures Act.” www.GovTrack.us. 2015. August 18, 2017 <https://www.govtrack.us/congress/bills/114/s289>
|title=S. 289 (114th)
|accessdate=August 18, 2017
|author=114th Congress (2015)
|date=January 28, 2015
|quote=American Cures Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.